Diagnóstico precoz del cáncer de mama con mamografía ¿merece la pena?
Resumen
El cáncer de mama (CM) es actualmente la segunda neoplasia más frecuente a nivel global, siendo con diferencia el tumor más frecuentemente diagnosticado en mujeres. Aparte de su elevada incidencia, la mortalidad por cáncer de mama supone la quinta causa global de muerte por cáncer. Esta elevada incidencia y mortalidad, añadido a la más difícil de calcular morbilidad que genera y costes sanitarios conlleva la necesidad de reducir la incidencia y la mortalidad. ¿Es la mamografía una buena médida?
Descargas
La descarga de datos todavía no está disponible.
Citas
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015, Mar 1;136(5):E359-86.
2. Duffy SW, Tabár L, Chen H-H, Holmqvist M, Yen M-F, Abdsalah S, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven swedish counties. Cancer 2002;95(3):458-69.
3. Tabar L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW. Number needed to screen: Lives saved over 20 years of follow-up in mammographic screening. J Med Screen 2004;11(3):126-9.
4. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, Oct 27;353(17):1784-92.
5. Group SOSSE. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiology Biomarkers & Prevention 2006;15(1):45.
6. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med 2009, Nov 17;151(10):716-26, W-236.
7. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013, Jun 4(6):CD001877.
8. Kopans DB, Halpern E, Hulka CA. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the national breast screening study of canada. Cancer 1994, Aug 15;74(4):1196-203.
9. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997(22):87-92.
10. U.S. Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 2002, Sep 3;137(5 Part 1):344-6.
11. Miller AB, Baines CJ, To T, Wall C. Canadian national breast screening study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992, Nov 15;147(10):1459-76.
12. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial steering group. J Med Screen 1999;6(3):144-8.
13. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med 2011, Sep 15;365(11):1025-32.
14. Bailey SL, Sigal BM, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. J Natl Cancer Inst 2010, Aug 18;102(16):1263-71.
15. Kopans DB, Smith RA, Duffy SW. Mammographic screening and "overdiagnosis". Radiology 2011, Sep;260(3):616-20.
16. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology 2011, Jan;258(1):98-105.
17. Tyndel S, Austoker J, Henderson BJ, Brain K, Bankhead C, Clements A, Watson EK. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS management group. J Clin Oncol 2007, Sep 1;25(25):3823-30.
18. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. Obstetrical & Gynecological Survey 2006;61(3):178.
2. Duffy SW, Tabár L, Chen H-H, Holmqvist M, Yen M-F, Abdsalah S, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven swedish counties. Cancer 2002;95(3):458-69.
3. Tabar L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW. Number needed to screen: Lives saved over 20 years of follow-up in mammographic screening. J Med Screen 2004;11(3):126-9.
4. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, Oct 27;353(17):1784-92.
5. Group SOSSE. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiology Biomarkers & Prevention 2006;15(1):45.
6. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med 2009, Nov 17;151(10):716-26, W-236.
7. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013, Jun 4(6):CD001877.
8. Kopans DB, Halpern E, Hulka CA. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the national breast screening study of canada. Cancer 1994, Aug 15;74(4):1196-203.
9. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997(22):87-92.
10. U.S. Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 2002, Sep 3;137(5 Part 1):344-6.
11. Miller AB, Baines CJ, To T, Wall C. Canadian national breast screening study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992, Nov 15;147(10):1459-76.
12. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial steering group. J Med Screen 1999;6(3):144-8.
13. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med 2011, Sep 15;365(11):1025-32.
14. Bailey SL, Sigal BM, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. J Natl Cancer Inst 2010, Aug 18;102(16):1263-71.
15. Kopans DB, Smith RA, Duffy SW. Mammographic screening and "overdiagnosis". Radiology 2011, Sep;260(3):616-20.
16. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology 2011, Jan;258(1):98-105.
17. Tyndel S, Austoker J, Henderson BJ, Brain K, Bankhead C, Clements A, Watson EK. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS management group. J Clin Oncol 2007, Sep 1;25(25):3823-30.
18. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. Obstetrical & Gynecological Survey 2006;61(3):178.
Publicado
22/11/2017
Número
Sección
Actualidad médica
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial 4.0.
Todos los trabajos publicados en la revista Clínica están sujetos a una licencia "Creative Commons Reconocimiento-No Comercial 4.0. España" (CC-by-nc).
Los autores continúan como propietarios de sus trabajos, y pueden volver a publicar sus artículos en otro medio sin tener que solicitar autorización, siempre y cuando indiquen que el trabajo fue publicado originariamente en la revista Clínica.
